Skip to main content

EDITORIAL article

Front. Pharmacol., 13 April 2023
Sec. Translational Pharmacology
This article is part of the Research Topic Advanced Nanotechnological Detection and Drug Delivery Configurations View all 6 articles

Editorial: Advanced nanotechnological detection and drug delivery configurations

  • 1Nanomaterials and Polymer Nanocomposites Laboratory, School of Engineering, University of British Columbia, Kelowna, BC, Canada
  • 2Health Policy Research Center, Health Institute, Shiraz University of Medica Sciences, Shiraz, Iran
  • 3Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei, Taiwan
  • 4Department of Mechanical Engineering, Center for Nanofibers and Nanotechnology, National University of Singapore, Singapore, Singapore

The widespread of infectious diseases and the advent of complex illnesses because of the human lifestyle led to considerable human pathogenesis and subsequent mortality, leaving a massive loss on the shoulder of human society (Gholami et al., 2020; Hashemi et al., 2021c). Even with the considerable investment of healthcare systems in sensitive detection approaches and wise treatment strategies, the world still encounters the flaw of fast person-to-person transferable pathogens that sometimes surpass cardiovascular diseases and cancer. This matter necessitates systematic investigations in the discovery of novel drugs with low side effects and sensitive detection approaches in a highly specific manner (Mousavi et al., 2019; Hashemi et al., 2021a; Hashemi et al., 2021b; Hashemi et al., 2022a; Hashemi et al., 2022b).

This Research Topic entitled “Advanced Nanotechnological Detection and Drug Delivery Configurations” is established with the aid of five expert editors with expertise in different disciplines toward promoting the current knowledge of drug discovery and advanced detection approaches. The Research Topic was prosperous, and five articles, including four original research articles and one review paper, were published after a rigorous peer review process supported by expert reviewers in the field.

Summarizing the published original research articles in the Research Topic, Dhondt et al. unveiled the contribution of fluid therapy in developing augmented renal clearance (ARC) in piglet models. Their study focused on the fluid administration of renal function by employing a piglet animal model to quantify the effect of fluid administration on the pharmacokinetic effects of the renally excreted drugs. Their study suggested the key impact of fluid therapy on the key factors of the ARC that should be considered upon the administration of the renally excreted drugs.

Huang et al. summarized and evaluated 10 years of progression in the field of gene therapy, focusing on the usage of nanomedicine and the problems in their transition into active use. Their study suggested the potential impact of several technologies in the case of targeted drug delivery. Accordingly, the systematic evolution of ligands by exponential enrichment (SELEX) and aptamer systems were found to be potent drug delivery configurations. The smart gene editing through clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein 9 (Cas9) is recognized as another method of target-oriented and specific disease treatment that showcased promising results in cancer therapy. The exosomes and their derivatives were also suggested as promising intelligent drug delivery systems for treating complex illnesses. This comprehensive study is a useful tool for decision-makers to put effort into the most practical strategies for specific and efficient disease treatment.

Zhu et al. correlated the ion channel gene signatures with the prognosis, diagnosis, and individualized treatments in patients with clear cell renal cell carcinoma (ccRCC). For this case, they extracted the RNA profiles, clinical data of patients with ccRCC, and public databases to propose a proper diagnosis approach and timely treatment techniques upon monitoring the level of ion-channel-related genes, known as specific biomarkers toward monitoring the typical structure of the kidney. Xian and co-workers (Xiang et al., 2022) investigated the potential of Ligusticum Chuanxiong as a traditional Chinese medicine against Osteoarthritis using network pharmacology and molecular docking. These two investigations highlighted the potential of in-depth data analysis in designing and finding the most effective treatment technique and/or diagnosis approach for complex illnesses with fewer clinical and animal trials.

In a review study published in the Research Topic, Ge et al. reviewed the potential of the PEGylated lipid-based configurations for small interfering RNA (siRNA) as a potential treatment tool. Based on their review, the long-circulating lifetime, biocompatibility, low toxicity, and ease of scale-up made the PEGylated lipid-based configurations versatile delivery systems for nucleic acids. They also investigated the recent progress in the case of these exciting drug delivery systems and provided the challenges they encounter and possible strategies to address them.

Author contributions

All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Gholami, A., Mousavi, S. M., Hashemi, S. A., Ghasemi, Y., Chiang, W.-H., and Parvin, N. (2020). Current trends in chemical modifications of magnetic nanoparticles for targeted drug delivery in cancer chemotherapy. Drug Metab. Rev. 52, 205–224. doi:10.1080/03602532.2020.1726943

PubMed Abstract | CrossRef Full Text | Google Scholar

Hashemi, S. A., Bahrani, S., Mousavi, S. M., Omidifar, N., Arjmand, M., Behbahan, N. G. G., et al. (2021a). Ultrasensitive biomolecule-less nanosensor based on β-cyclodextrin/quinoline decorated graphene oxide toward prompt and differentiable detection of corona and influenza viruses. Adv. Mater. Technol. 6, 2100341. doi:10.1002/admt.202100341

CrossRef Full Text | Google Scholar

Hashemi, S. A., Bahrani, S., Mousavi, S. M., Omidifar, N., Behbahan, N. G. G., Arjmand, M., et al. (2021b). Graphene-based femtogram-level sensitive molecularly imprinted polymer of SARS-CoV-2. Adv. Mater. Interfaces 8, 2101466. doi:10.1002/admi.202101466

PubMed Abstract | CrossRef Full Text | Google Scholar

Hashemi, S. A., Behbahan, N. G. G., Bahrani, S., Mousavi, S. M., Gholami, A., Ramakrishna, S., et al. (2021c). Ultra-sensitive viral glycoprotein detection NanoSystem toward accurate tracing SARS-CoV-2 in biological/non-biological media. Biosens. Bioelectron. 171, 112731. doi:10.1016/j.bios.2020.112731

PubMed Abstract | CrossRef Full Text | Google Scholar

Hashemi, S. A., Bahrani, S., Mousavi, S. M., Omidifar, N., Arjmand, M., Lankarani, K. B., et al. (2022a). Differentiable detection of ethanol/methanol in biological fluids using prompt graphene-based electrochemical nanosensor coupled with catalytic complex of nickel oxide/8-hydroxyquinoline. Anal. Chim. Acta 1194, 339407. doi:10.1016/j.aca.2021.339407

PubMed Abstract | CrossRef Full Text | Google Scholar

Hashemi, S. A., Bahrani, S., Mousavi, S. M., Omidifar, N., Behbahan, N. G. G., Arjmand, M., et al. (2022b). Antibody mounting capability of 1D/2D carbonaceous nanomaterials toward rapid-specific detection of SARS-CoV-2. Talanta 239, 123113. doi:10.1016/j.talanta.2021.123113

PubMed Abstract | CrossRef Full Text | Google Scholar

Mousavi, S. M., Hashemi, S. A., Ghasemi, Y., Amani, A. M., Babapoor, A., and Arjmand, O. (2019). Applications of graphene oxide in case of nanomedicines and nanocarriers for biomolecules: Review study. Drug metab. Rev. 51, 12–41. doi:10.1080/03602532.2018.1522328

PubMed Abstract | CrossRef Full Text | Google Scholar

Xiang, C., Liao, Y., Chen, Z., Xiao, B., Zhao, Z., Li, A., et al. (2022). Network pharmacology and molecular docking to elucidate the potential mechanism of Ligusticum Chuanxiong against osteoarthritis. Front. Pharmacol. 13, 854215. doi:10.3389/fphar.2022.854215

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: detection, drug delivery systems, nanomedicine, treatment, diagnostic

Citation: Hashemi SA, Arjmand M, Lankarani KB, Chiang W-H and Ramakrishna S (2023) Editorial: Advanced nanotechnological detection and drug delivery configurations. Front. Pharmacol. 14:1198100. doi: 10.3389/fphar.2023.1198100

Received: 31 March 2023; Accepted: 04 April 2023;
Published: 13 April 2023.

Edited and reviewed by:

Alastair George Stewart, The University of Melbourne, Australia

Copyright © 2023 Hashemi, Arjmand, Lankarani, Chiang and Ramakrishna. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Seyyed Alireza Hashemi, s.a.hashemi0@gmail.com, alireza.hashemi@ubc.ca

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.